Epivir Related Clinical Trials
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment [Active, not recruiting]
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine [Active, not recruiting]
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Active, not recruiting]
Virologic and Immunologic Activity of Continued Lamivudine (3TC) Vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects [Completed]
Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients [Recruiting]
Comparison Between Lamivudine and Entecavir Treatment in Patients [Not yet recruiting]
3TC (Lamivudine; GR109714X) Open-Label Program [Completed]
Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma [Not yet recruiting]
Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz [Recruiting]
TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA [Recruiting]
Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) [Completed]
Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand [Recruiting]
Study of Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. [Active, not recruiting]
Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA [Recruiting]
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA [Recruiting]
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA [Recruiting]
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy [Recruiting]
Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding [Recruiting]
Efficacy of Clevudine Plus Lamivudine for Lamivudine-Resistant Chronic Hepatitis B Patients [Recruiting]
The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs [Completed]
Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression [Recruiting]
Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B [Recruiting]
The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens [Completed]
A Comparison of Nelfinavir Plus Saquinavir Plus Delavirdine or 3TC/ZDV Versus Nelfinavir Plus 3TC/ZDV in HIV-Infected Patients [Terminated]
The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs [Completed]
A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC [Completed]
Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy [Recruiting]
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects. [Completed]
Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals [Completed]
A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants [Active, not recruiting]
A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants [Active, not recruiting]
To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir. [Completed]
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients [Completed]
Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B [Completed]
Study of Options for Second-Line Effective Combination Therapy (SELECT) [Recruiting]
A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [Completed]
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past [Completed]
A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs [Completed]
Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine [Completed]
A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children [Completed]
Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients [Not yet recruiting]
A Study of Two Anti-HIV Drug Combinations [Completed]
Abacavir and Lamivudine PK in Children [Recruiting]
A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy [Recruiting]
Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [Completed]
Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients [Recruiting]
Lamivudine for Chronic Hepatitis B [Completed]
Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT) [Recruiting]
A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants [Active, not recruiting]
Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Na�ve HIV-1 Infected Subjects. [Recruiting]
Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients [Recruiting]
Safety, Efficacy and Dose-response Study of BMS-986001 in Subjects With HIV-1 Infection Who Are Treatment-naive [Recruiting]
Efficacy Optimizing Research of Lamivudine Therapy [Recruiting]
A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months [Completed]
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks [Completed]
Atazanavir and Lamivudine for Treatment Simplification [Not yet recruiting]
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine [Not yet recruiting]
Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs [Completed]
Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination [Completed]
Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects [Completed]
Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV [Completed]
The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients [Completed]
An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B [Completed]
Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs [Completed]
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily [Completed]
Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) [Terminated]
Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns [Completed]
Lactic Acidosis During Entecavir(ETV)Treatment [Not yet recruiting]
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC [Completed]
The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine [Completed]
The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs [Completed]
A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs [Completed]
Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy Instead of a Triple Therapy That Includes Lopinavir/Ritonavir and Lamivudine or Emtricitabine in HIV Patients With Viral Suppression [Recruiting]
Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies [Completed]
Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients [Active, not recruiting]
Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B [Recruiting]
A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir [Completed]
Zidovudine and Lamivudine Given Once Versus Twice Daily [Active, not recruiting]
Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age [Recruiting]
The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection [Completed]
A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients [Completed]
Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV [Active, not recruiting]
A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients [Completed]
Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients [Recruiting]
Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children [Recruiting]
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT [Completed]
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients [Completed]
3TC or No 3TC for HIV With 3TC Resistance [Recruiting]
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients [Completed]
A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine [Suspended]
A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine [Completed]
A Comparison of Two Drug Combinations Used in HIV-Infected Patients Who Never Have Taken Anti-HIV Drugs [Completed]
A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients [Completed]
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults [Completed]
Lamivudine and Adefovir to Treat Chronic Hepatitis B [Active, not recruiting]
Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children [Active, not recruiting]
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus [Recruiting]
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs [Active, not recruiting]
Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [Active, not recruiting]
Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT [Completed]
Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis B [Recruiting]
|
